Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

RA Capital Nexus Fund, L.P. bought 6,522 Artiva Biotherapeutics, Inc. shares (Form 4/A)

Traded Jul 13, 2026 · Filed Jul 23, 2026

On Jul 13, 2026, RA Capital Nexus Fund, L.P. (Director) bought 6,522 Artiva Biotherapeutics, Inc. shares at US$8.94 for US$58,307, leaving 16,817,543 shares. Filed Jul 23, 2026 (Form 4/A).

Bought
6,522 shares
Price
US$8.94
Value
US$58,307
Holding after
16,817,543 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 13, 2026Common StockBuy6,522US$8.9416,817,543Indirect

Source

View original at SEC

Related